As part of its UMBRELLA study, numares HEALTH has discovered a urinalysis procedure for diagnosing the impending rejection of a transplanted kidney. By the end of 2016, [...]

The SHS portfolio company TNI medical is receiving further funding in a second financing round. Two new investors - the Portuguese investment firm Pathena and a private [...]

Regensburg-based company numares has developed a new test system for use in diagnostic lipid analysis, the AXINON lipoFIT-S100-400. In early 2015, numares launched the AXINON lipoFIT-S100, its [...]

With its fourth fund, the Tübingen based medical technology investor SHS Gesellschaft für Beteiligungsmanagement has acquired all shares of Novo Klinik-Service GmbH. The company is based in [...]

The fund SHS IV has invested in GNA Biosolutions GmbH together with existing and new investors. GNA, a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh [...]

The U.S. based laboratory HEALTH DIAGNOSTIC LABORATORY, Inc. (HDL, Inc.) has performed 500,000 tests for the determination of lipoproteins since the first devices were installed at HDL, [...]